US FDA approves Vanda's antipsychotic pill, shares climb
US FDA approves Vanda's antipsychotic pill, shares climb is drawing significant interest across the industry.
The U.S. Food and Drug Administration has approved Vanda Pharmaceuticals' drug for the treatment of two serious mental health conditions, the company said on Friday, sending its shares surging 30% in...
Experts suggest this could influence future trends and innovation in the sector.
More updates are expected as the story develops.
Related Articles
- The West Brom Opta prediction on Championship table - and it is not good at all for Albion fans
- EPFO to launch new mobile app for UPI
- EA continues to ‘evolve’ The Sims 4 with new virtual currency and a ‘maker’ program
- Black Celebrities Who Changed Names Or Appearances For Hollywood
Source: Original →